FIELD: pharmaceuticals.
SUBSTANCE: proposed use of 3β,5α,6β-trihydroxyl steroid compound of formula A or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for prevention or treatment of altitude sickness caused by hypobaric hypoxia. 
.
EFFECT: as a result, 5α-androstane-3β,5,6β-triol and its salts effectively reduce the vasogenic edema of the brain tissue in the cynomolgus macaques (Macaca fascicularis), caused by hypobaric hypoxia, reduce the increased water content in the brain and provide protection against neuronal vacuolar degeneration caused by hypobaric hypoxia – so it or its salts can improve neurological dysfunctions, caused by hypobaric hypoxia, and are suitable for the prevention or treatment of altitude sickness.
7 cl, 3 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USING 5?-ANDROSTANE-3(,5,6(-TRIOL FOR PREPARING NEUROPROTECTIVE DRUGS | 2011 |
|
RU2541093C2 |
| APPLICATION OF THE COMPOUND FOR THE PREPARATION OF A DRUG FOR THE TREATMENT OF CEREBRAL MICROANGIOPATHY | 2018 |
|
RU2752089C1 |
| INJECTABLE FORM OF 5α ANDROSTANE-3β,5,6β-TRIOL AND METHOD FOR PREPARING IT | 2011 |
|
RU2532354C1 |
| APPLICATION OF COMPOUNDS FOR PRODUCING MEDICINAL PRODUCT FOR TREATING HEMORRHAGIC STROKE | 2018 |
|
RU2752090C1 |
| CRYSTALLINE FORMS OF 5α-ANDROSTANE-3β,5,6β-TRIOL AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2608894C2 |
| NEUROACTIVE STEROIDS, PHARMACEUTICAL PREPARATION, METHOD OF TREATMENT AND PROPHYLAXIS OF DIFFERENT DISORDERS, METHOD OF SLEEP INDUCTION AND METHOD OF ANESTHESIA INDUCTION WITH THEIR USING, METHOD OF MODULATION OF COMPLEX RECEPTOR GABAA-CHLORIDE IONOPHORE | 1996 |
|
RU2194712C2 |
| 2(,3(,5(-TRIHYDROXY-ANDROST-6-ONE, METHODS FOR ITS PRODUCTION AND APPLICATION | 2014 |
|
RU2629929C2 |
| ANDROSTANES | 1995 |
|
RU2160740C2 |
| STERILE AQUEOUS PHARMACEUTICAL COMPOSITION BASED ON LAZAROID OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR PARENTERAL ADMINISTRATION | 1995 |
|
RU2152789C2 |
| REMEDY FOR PREVENTING EDEMA | 1988 |
|
RU2049464C1 |
